Guidant Fights Plaintiffs' Bid For Sanctions

Law360, New York (July 2, 2007, 12:00 AM EDT) -- On the eve of the first bellwether trial over Guidant Corp.'s allegedly defective implantable heart defibrillators, the medical device maker has lashed out at the plaintiffs' bid to sanction one of Guidant's nonretained expert witnesses, calling the move “a baseless and unprofessional attack.”

Guidant—which was acquired by Boston Scientific Corp. last year—said in court documents filed June 29 that the court should deny the plaintiffs' motion for sanctions regarding Dr. Stephen Higgins, arguing that the request is a “last-ditch, desperate attempt to lodge groundless ethical complaints...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.